Literature DB >> 17076601

Emollient foam in topical drug delivery.

Dov Tamarkin1, Doron Friedman, Avner Shemer.   

Abstract

Foams offer an innovative and more convenient means of topical drug delivery. The successful introduction of hydroalcoholic foams paved the way for the development of a new generation of foam products that provide skin barrier build-up and hydration. Such foams, designated as emollient foams consist of oil-in-water or water-in-oil emulsions with necessary excipients, such as non-ionic surfactants, gelling agents and foam adjuvants. Emollient foams can carry a broad variety of topical drugs, including water-soluble, oil-soluble and suspended active agents. This paper reviews emollient foam compositions and their physicochemical properties. It further accounts for the usability and functional advantages of emollient foam as a vehicle of topical drugs, including: i) improved usability, which affects treatment, compliance and, consequently, improves therapeutic results; ii) safety; iii) controllable drug delivery; iv) skin barrier build-up and hydration; and v) enhanced clinical efficacy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17076601     DOI: 10.1517/17425247.3.6.799

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  6 in total

1.  Rate of Adverse Events and Healthcare Costs Associated with the Topical Treatment of Rosacea.

Authors:  Todd Williamson; Rajesh Kamalakar; Augustina Ogbonnaya; Erin A Zagadailov; Michael Eaddy; Charlie Kreilick
Journal:  Am Health Drug Benefits       Date:  2017-05

2.  Responsive foams for nanoparticle delivery.

Authors:  Christina Tang; Edward Xiao; Patrick J Sinko; Zoltan Szekely; Robert K Prud'homme
Journal:  Colloids Surf B Biointerfaces       Date:  2015-05-27       Impact factor: 5.268

3.  Expansible thermal gelling foam aerosol for vaginal drug delivery.

Authors:  Liling Mei; Jintian Chen; Siqin Yu; Ying Huang; Yecheng Xie; Hui Wang; Xin Pan; Chuanbin Wu
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

4.  Preparation and evaluation of minoxidil foamable emu oil emulsion.

Authors:  M A Shatalebi; Y Rafiei
Journal:  Res Pharm Sci       Date:  2014 Mar-Apr

5.  Complying with the Guideline for Quality and Equivalence for Topical Semisolid Products: The Case of Clotrimazole Cream.

Authors:  Teresa Alves; Daniel Arranca; Ana Martins; Helena Ribeiro; Sara Raposo; Joana Marto
Journal:  Pharmaceutics       Date:  2021-04-14       Impact factor: 6.321

6.  General practice recommendations for the topical treatment of psoriasis: a modified-Delphi approach.

Authors:  Diamant Thaçi; Pablo de la Cueva; Andrew E Pink; Ahmad Jalili; Siegfried Segaert; Kasper F Hjuler; Piergiacomo Calzavara-Pinton
Journal:  BJGP Open       Date:  2020-12-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.